Virological outcomes and genotypic resistance on dolutegravirbased antiretroviral therapy versus standard of care in children and adolescents a secondary analysis of the ODYSSEY trial

Abstract

Description

Keywords

Citation

WOS

Endorsement

Review

Supplemented By

Referenced By